Highlights From Atlantic Coast Retina Club and Macula 2026 - Scorecard - MDSpire

Highlights From Atlantic Coast Retina Club and Macula 2026

  • By

  • Trisha Ortiz, BS

  • Omar Masoud, MD

  • Alexander Shaer, BS

  • Yoshihiro Yonekawa, MD

  • January 1, 2026

  • 8 min

Share

Clinical Scorecard: Highlights From Atlantic Coast Retina Club and Macula 2026

At a Glance

CategoryDetail
ConditionRetinal Diseases
Key MechanismsEmerging therapies and surgical approaches for retinal conditions, including age-related macular degeneration and diabetic macular edema.
Target PopulationPatients with retinal diseases, including diabetic retinopathy and inherited retinal diseases.
Care SettingOphthalmology clinics and retina specialty centers.

Key Highlights

  • Presentation of novel treatments for ocular oncology and tumor cases.
  • Discussion on the effectiveness of intra-arterial chemotherapy in retinoblastoma and melanoma.
  • Emerging role of intravitreal tyrosine kinase inhibitors in diabetic retinopathy.
  • Importance of genetic evaluation in inherited retinal diseases.
  • Real-world deviations from established treatment protocols in diabetic retinopathy.

Guideline-Based Recommendations

Diagnosis

  • Utilize multimodal imaging and ancillary testing for accurate diagnosis of retinal diseases.
  • Consider genetic evaluation in cases of inherited retinal diseases.

Management

  • Intra-arterial chemotherapy may be preferred over systemic chemotherapy in select cases.
  • Intravitreal tyrosine kinase inhibitors may provide comparable outcomes to anti-VEGF therapy.

Monitoring & Follow-up

  • Regular follow-up for patients with diabetic retinopathy and macular edema.
  • Monitor for ocular side effects of GLP-1 receptor agonists.

Risks

  • Potential side effects of treatments, including those from GLP-1 receptor agonists.
  • Consideration of trauma-related risks in patients with inherited retinal diseases.

Patient & Prescribing Data

Patients with diabetic retinopathy, age-related macular degeneration, and inherited retinal diseases.

Individualized treatment strategies based on visual acuity and OCT findings.

Clinical Best Practices

  • Encourage protective eyewear in patients with inherited retinal diseases.
  • Consider alternative therapies when conventional treatments are not effective.
  • Maintain a multidisciplinary approach for complex retinal cases.

Related Resources & Content

Original Source(s)

Related Content